FRA:YMP3
Delisted

Symphony Holdings Limited Stock Price (Quote)

0.0890€
+0 (+0%)
At Close: Aug 17, 2022

Range Low Price High Price Comment
30 days 0.0890€ 0.0890€ Wednesday, 17th Aug 2022 YMP3.F stock ended at 0.0890€. During the day the stock fluctuated 0% from a day low at 0.0890€ to a day high of 0.0890€.
90 days 0.0890€ 0.0890€
52 weeks 0.0890€ 0.0905€

Historical Symphony Holdings Limited prices

Date Open High Low Close Volume
2022-08-17 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
2022-08-16 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
2022-08-15 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
2022-08-12 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
2022-08-11 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
2022-08-10 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
2022-08-09 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
2022-08-08 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
2022-08-05 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
2022-08-04 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
2022-08-03 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
2022-08-02 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
2022-08-01 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
2022-07-29 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
2022-07-28 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
2022-07-27 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
2022-07-26 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
2022-07-25 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
2022-07-22 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
2022-07-21 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
2022-07-20 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
2022-07-19 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
2022-07-18 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
2022-07-15 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
2022-07-14 0.0890€ 0.0890€ 0.0890€ 0.0890€ 0
Click to get the best stock tips daily for free!

About Symphony Holdings Limited

Symphony Holdings Limited Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... YMP3.F Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT